• TH
    • EN
    • Register
    • Login
    • Forgot Password
    • Help
    • Contact
  • Register
  • Login
  • Forgot Password
  • Help
  • Contact
  • EN 
    • TH
    • EN
View Item 
  •   Home
  • สถาบันวิจัยระบบสาธารณสุข (สวรส.) - Health Systems Research Institute (HSRI)
  • Research Reports
  • View Item
  •   Home
  • สถาบันวิจัยระบบสาธารณสุข (สวรส.) - Health Systems Research Institute (HSRI)
  • Research Reports
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Surveillance of Cannabis Intoxication in Public Hospital Emergency Departments

ชัยสิริ อังกุระวรานนท์; Chaisiri Angkurawaranon; นิศาชล เดชเกรียงไกรกุล; Nisachol Dejkriengkraikul; บวร วิทยชำนาญกุล; Borwon Wittayachamnankul; ธีรพล ตั้งสุวรรณรักษ์; Theerapon Tangsuwanaruk; จิตรลดา ลิ้มจินดาพร; Chitlada Limjindaporn; ฐปนวงศ์ มิตรสูงเนิน; Thapanawong Mitsungnern; ณัฐมนต์ ศรีสุข; Natthamon Srisook;
Date: 2568-07
Abstract
Objectives To monitor cannabis intoxication in emergency departments in public hospital. The monitor includes both intoxication from medical cannabis and cannabis use for other purposes. Methods The surveillance was conducted in patients visiting emergency rooms with a history of cannabis use or were found to have symptoms caused by cannabis. Four surveillance sites were Maharaj Nakorn Chiang Mai Hospital (Chiang Mai), Thammasat Chalermprakiet Hosipital (Pathum Thani), Srinakarin Hospital (Khon Kean) and Songklanagarindra Hospital (Songkhla). The total surveillance period was 12 months from September 16, 2023 to September 15, 2024. Key finding Within 12-months surveillance, the total of 51 volunteers were included in the study. There were more male than female. With 35 volunteers were male (68.63 %). The average age were 30.04 years old. Urine THC tested positive in 38 cases of 40 cases tested (95%). Most volunteers had no underlying medical conditions. Physical symptoms were most prevalent in volunteers with cannabis intoxication. Palpitation and mouth dryness were the most common symptoms (found in more than half of the volunteers). Dizziness, nausea, vomiting and drowsiness were the next most common symptom (ranging from 30-50%) Mental symptoms were found in 33% of volunteers including dysphoria, fear, panic, Psychomotor impairment, and psychosis. Most volunteers had mild symptoms. Only 2 volunteers (3.92%) were admitted for in-patient care. Forty-three volunteers (84.31%) had history of cannabis use. About half of the volunteers smoked cannabis (52.94%). Other cannabis products included cannabis-infused snacks in 20 volunteers (39.22%), cannabis oil in 5 volunteers (9.80%), and cannabis pill/ cannabis in a form of herbal medicines in 1 volunteer (3.92%). The purposes of use were entertainment in 20 volunteers (39.22%), sleep aid in 10 volunteers (19.61%), mood improvement in 10 volunteers (19.61%), unintentional use in 5 volunteers (9.80%), experimentation in 4 volunteers (7.84%), pain relief in 1 volunteer (1.96%), health maintenance in 1 volunteer (1.96%), and unknown purposes in 6 volunteers (11.76%). THC, CBD and 11-OH-THC levels were measured in plasma from 25 volunteers (49.02%). THC was detected in all plasma samples, with an average concentration of 1.810 ng/ml. The minimum THC level was 0.198 ng/ml, and the maximum was 10.473 ng/ml. CBD was detected in 24 plasma samples (96% of plasma samples), with an average concentration of 0.358 ng/ml. In 13 samples (54% of CBD-detected plasma), the CBD level was less than 0.1 ng/ml, and the maximum CBD level was 5.073 ng/ml. 11-OH-THC were also detected in all plasma samples with an average level of 1.600 ng/ml. The minimum 11-OH-THC level was 0.072 ng/ml, and the maximum was 6.985 ng/ml. Twenty urine samples were collected (39.22%). COOH-THC were detected in 19 urine samples (95% of urine samples). The average level of COOH-THC was 196.330 ng/ml (maximum 1318.098 ng/ml). Urine COOH-THC levels did not show a direct correlation with plasma THC levels, as multiple factors can influence the excretion of COOH-THC in urine. One important factor is that regular use of THC results in higher concentrations and a longer duration of COOHTHC detection in urine compared to single use. Co-use of other substances was found in 21 volunteers (41.17%). The most common coused substance was alcohol, found in 12 volunteers (23.53%). Other substances were Kratom in 4 volunteers (7.84%), tramadol in 3 volunteers (5.88%), methamphetamine in 1 volunteer (1.98%), opioid in 1 volunteer (1.98%) and sleeping pill in 1 volunteer (1.98%). Opinion of the research team During the early period of cannabis legalization, there were more patients presenting to the emergency department with cannabis intoxication compared to the period during which our data were collected. In the opinion of the research team, this may be because new users were not yet familiar with the symptoms associated with cannabis use. As the number of new users declined, previous users became more aware of the effects of cannabis and understood that these effects are typically not life-threatening. Some cases of cannabis intoxication were the result of accidental ingestion. Regulations should be implemented to permit cannabis use only for medical purposes in order to minimize negative societal impacts. Our research team also found that some cannabis users were adolescents. Cannabis use during adolescence can have long-lasting effects on brain development. Most adolescent cannabis users used cannabis for recreational purposes. Therefore, stricter regulations and better monitoring systems should be established to prevent cannabis access among adolescents. Further studies on the health and social effects of cannabis use should be considered. The research team suggests anonymized data collection to help ensure unbiased results, given the high rate of participation denial and possible fears of legal consequences among potential participants.
Copyright ผลงานวิชาการเหล่านี้เป็นลิขสิทธิ์ของสถาบันวิจัยระบบสาธารณสุข หากมีการนำไปใช้อ้างอิง โปรดอ้างถึงสถาบันวิจัยระบบสาธารณสุข ในฐานะเจ้าของลิขสิทธิ์ตามพระราชบัญญัติสงวนลิขสิทธิ์สำหรับการนำงานวิจัยไปใช้ประโยชน์ในเชิงพาณิชย์
Fulltext
Thumbnail
Name: hs3284.pdf
Size: 665.0Kb
Format: PDF
Download

User Manual
(* In case of download problems)

Total downloads:
Today: 1
This month: 1
This budget year: 1
This year: 1
All: 1
 

 
 


 
 
Show full item record
Collections
  • Research Reports [2506]

    งานวิจัย


DSpace software copyright © 2002-2016  DuraSpace
Privacy Policy | Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

Browse

HSRI Knowledge BankDashboardCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjectsSubjectsการบริการสุขภาพ (Health Service Delivery) [624]กำลังคนด้านสุขภาพ (Health Workforce) [101]ระบบสารสนเทศด้านสุขภาพ (Health Information Systems) [287]ผลิตภัณฑ์ วัคซีน และเทคโนโลยีทางการแพทย์ (Medical Products, Vaccines and Technologies) [126]ระบบการเงินการคลังด้านสุขภาพ (Health Systems Financing) [160]ภาวะผู้นำและการอภิบาล (Leadership and Governance) [1306]ปัจจัยสังคมกำหนดสุขภาพ (Social Determinants of Health: SDH) [233]วิจัยระบบสุขภาพ (Health System Research) [28]ระบบวิจัยสุขภาพ (Health Research System) [21]

DSpace software copyright © 2002-2016  DuraSpace
Privacy Policy | Contact Us | Send Feedback
Theme by 
Atmire NV